Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcomes of FOLFIRINOX and gemcitabine-nab paclitaxel for metastatic pancreatic cancer in the real world setting.
Franco F, Camara JC, Martín-Valadés JI, López-Alfonso A, Marrupe D, Gutiérrez-Abad D, Martínez-Amores B, León A, Juez I, Pérez M, Royuela A, Ruiz-Casado A. Franco F, et al. Among authors: juez i. Clin Transl Oncol. 2021 Apr;23(4):812-819. doi: 10.1007/s12094-020-02473-w. Epub 2020 Aug 28. Clin Transl Oncol. 2021. PMID: 32857340
Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?
Vera R, Mata E, González E, Juez I, Alonso V, Iranzo P, Martínez NP, López C, Cabrera JM, Safont MJ, Ruiz-Casado A, Salgado M, González B, Escudero P, Rivera F, Pericay C. Vera R, et al. Among authors: juez i. Int J Colorectal Dis. 2020 Apr;35(4):739-746. doi: 10.1007/s00384-020-03509-x. Epub 2020 Feb 15. Int J Colorectal Dis. 2020. PMID: 32062727
Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.
Jimeno A, Grávalos C, Escudero P, Sevilla I, Vega-Villegas ME, Alonso V, Juez I, García-Carbonero R, Bovio H, Colomer R, Cortés-Funes H. Jimeno A, et al. Among authors: juez i. Clin Transl Oncol. 2008 Jan;10(1):52-7. doi: 10.1007/s12094-008-0153-5. Clin Transl Oncol. 2008. PMID: 18208793 Clinical Trial.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study.
Martin-Richard M, Gallego R, Pericay C, Garcia Foncillas J, Queralt B, Casado E, Barriuso J, Iranzo V, Juez I, Visa L, Saigi E, Barnadas A, Garcia-Albeniz X, Maurel J. Martin-Richard M, et al. Among authors: juez i. Invest New Drugs. 2013 Dec;31(6):1573-9. doi: 10.1007/s10637-013-0020-2. Invest New Drugs. 2013. PMID: 24077981 Clinical Trial.
Validation of diagnostic methods for peritoneal carcinomatosis secondary to ovarian cancer. CT-scan, PET-CT or laparoscopy, what is the best?
Manzanedo I, Losada B, Martínez-Torres B, Pereira F, Serrano Á, Juez I, Pérez-Viejo E, Gutiérrez D, Peiró V, Aulló C. Manzanedo I, et al. Among authors: juez i. Minerva Ginecol. 2018 Aug;70(4):488-490. doi: 10.23736/S0026-4784.18.04182-5. Epub 2018 Feb 9. Minerva Ginecol. 2018. PMID: 29431339 No abstract available.
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA.
Huebner A, Black JRM, Sarno F, Pazo R, Juez I, Medina L, Garcia-Carbonero R, Guillén C, Feliú J, Alonso C, Arenillas C, Moreno-Cárdenas AB, Verdaguer H, Macarulla T, Hidalgo M, McGranahan N, Toledo RA. Huebner A, et al. Among authors: juez i. Genome Med. 2023 Apr 20;15(1):27. doi: 10.1186/s13073-023-01171-w. Genome Med. 2023. PMID: 37081523 Free PMC article.
12 results